ADMA BIOLOGICS, INC. Income Taxes Paid
ADMA BIOLOGICS, INC. (ADMA) reported Income Taxes Paid of $23.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-05
- ADMA BIOLOGICS, INC. income taxes paid for the quarter ending 2026-06-30 was $22.97M, a 233.43% increase year-over-year.
- ADMA BIOLOGICS, INC. income taxes paid for the quarter ending 2026-03-31 was $91.00K.
- ADMA BIOLOGICS, INC. income taxes paid for the quarter ending 2025-12-31 was $5.34M, a 974.04% increase year-over-year.
- ADMA BIOLOGICS, INC. income taxes paid for the quarter ending 2025-09-30 was $7.46M, a 1.50% increase year-over-year.
- ADMA BIOLOGICS, INC. income taxes paid for fiscal 2025 was $19.68M, a 109.57% increase from fiscal 2024.
- ADMA BIOLOGICS, INC. income taxes paid for fiscal 2024 was $9.39M.
- ADMA BIOLOGICS, INC. income taxes paid for fiscal 2023 was $0.00.
- ADMA BIOLOGICS, INC. income taxes paid for fiscal 2022 was $0.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $23.06M 10-Q · filed 2026-08-05 | $28.40M derived: sum of 3 quarters · filed 2026-08-05 | $35.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $91.00K 10-Q · filed 2026-05-06 | $5.43M derived: sum of 2 quarters · filed 2026-05-06 | $12.88M derived: sum of 3 quarters · filed 2026-05-06 | $19.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.79M derived: sum of 2 quarters · filed 2026-02-25 | $19.68M derived: sum of 3 quarters · filed 2026-08-05 | $19.68M 10-K · filed 2026-02-25 |
| 2025-09-30 | $7.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $14.35M derived: sum of 2 quarters · filed 2026-08-05 | $14.35M 10-Q · filed 2025-11-05 | $14.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.89M 10-Q · filed 2026-08-05 | $7.39M derived: sum of 3 quarters · filed 2026-08-05 | $14.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $497.00K derived: sum of 2 quarters · filed 2026-05-06 | $7.84M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.84M derived: sum of 2 quarters · filed 2026-02-25 | $9.39M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $7.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.89M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $1.55M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |